Bioxcel therapeutics announces proposed public offering of common stock

Bioxcel therapeutics announces proposed public offering of common stock.bioxcel therapeutics inc - commenced an underwritten public offering of $200.0 million of shares of its common stock.bioxcel - intends to use proceeds of offering to fund ongoing clinical trials, commercialization preparation, for general corporate purposes.
BTAI Ratings Summary
BTAI Quant Ranking